DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription, Age Group, Distribution Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmaceutical Manufacturing Market size was estimated at USD 454.02 billion in 2021, USD 509.45 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.38% to reach USD 914.90 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Drug Development Type, the market was studied across In-house and Outsource.
- Based on Formulation, the market was studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets.
- Based on Therapy Area, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases.
- Based on Route of Administration Outlook, the market was studied across Inhalations, Oral, Parenteral, and Topical.
- Based on Prescription, the market was studied across Over-the-counter (OTC) Medicines and Prescription Medicines.
- Based on Age Group, the market was studied across Adults, Children & Adolescents, and Geriatric.
- Based on Distribution Channels, the market was studied across Non-retail and Retail.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Companies Mentioned
- Actiza Pharmaceutical Pvt. Ltd.
- Aenova Group GmbH
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim Group
- Bristol-Myers Squibb
- Catalent Inc.
- Eli Lilly And Company
- F. Hoffmann-La Roche Ltd.
- Famar SA
- GlaxoSmithKline PLC
- Johnson & Johnson Private Limited
- Lonza Group AG
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Piramal Pharma Solutions
- Recipharm AB
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.
This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Manufacturing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Market Dynamics
Drivers
- Increase in global demand for vaccines and drugs
- Growing pharmaceutical R&D spending
- Growth in geriatric population and incidence rate of chronic disorders
Restraints
- Patent expiration of profitable drugs
Opportunities
- Rise in focus towards healthcare needs of emerging nations
- Rise in the investment and funding programs in pharmaceutical manufacturing sector
- Emergence in the advancements of pharmaceutical manufacturing technologies
Challenges
- Logistics complexities and limited skilled professionals
For more information about this report visit https://www.researchandmarkets.com/r/w21uk
